申请人:TAKEDA PHARMACEUTICALS CO
公开号:WO2016199943A1
公开(公告)日:2016-12-15
The present invention provides a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof has an BET family protein inhibitory action, and is useful as an agent for the prophylaxis or treatment of autoimmune diseases and/or inflammatory diseases (e.g., rheumatoid arthritis, multiple sclerosis, idiopathic pulmonary fibrosis, psoriasis, atopic dermatitis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, systemic lupus erythematosus etc.), cancer and the like.
本发明提供了一种化合物,其由式(I)表示,其中每个符号如规范中定义,或其盐具有BET家族蛋白抑制作用,并且可用作自身免疫疾病和/或炎症性疾病(例如类风湿关节炎、多发性硬化、特发性肺纤维化、牛皮癣、特应性皮炎、炎症性肠病、干燥综合征、贝赫切特病、系统性红斑狼疮等)、癌症等的预防或治疗剂。